Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Parkinsonism
ADR ID BADD_A03311
ADR Hierarchy
17      Nervous system disorders
17.01      Movement disorders (incl parkinsonism)
17.01.05      Parkinson's disease and parkinsonism
17.01.05.003      Parkinsonism
Description A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA. [MeSH]
MedDRA Code 10034010
MeSH ID D020734; D010302
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Drug-induced parkinsonism | Parkinson's syndrome | Parkinsonism | Parkinsonism aggravated | Parkinsonism post encephalitic | Pseudoparkinsonism | Secondary parkinsonism | Syndrome Parkinson's | Syndrome Parkinsonism | Hypokinetic-rigid syndrome | Akinetic rigid syndrome | Viral parkinsonism | Parkinsonian Disorders | Parkinsonian Syndrome | Parkinsonian Syndromes | Parkinsonian Diseases | Autosomal Dominant Parkinsonism | Dominant Parkinsonism, Autosomal | Parkinsonism, Autosomal Dominant | Autosomal Recessive Juvenile Parkinson Disease | Chromosome 6-Linked Autosomal Recessive Parkinsonism | Chromosome 6 Linked Autosomal Recessive Parkinsonism | Familial Parkinson Disease, Autosomal Recessive | Juvenile Parkinson Disease, Autosomal Recessive | Juvenile Parkinsonism, Autosomal Recessive | Parkinsonism, Early Onset, with Diurnal Fluctuation | Parkinsonism, Juvenile, Autosomal Recessive | Parkinson Disease 2, Autosomal Recessive Juvenile | Parkinsonism, Early-Onset, With Diurnal Fluctuation | Parkinson Disease, Juvenile, Autosomal Recessive | Parkinson Disease 2 | Parkinson Disease Autosomal Recessive, Early Onset | Autosomal Recesssive Juvenile Parkinsonism | Parkinson Disease, Familial, Autosomal Recessive | Ramsay Hunt Paralysis Syndrome | Familial Juvenile Parkinsonism | Juvenile Parkinsonism, Familial | Parkinsonism, Familial Juvenile | Parkinsonism, Experimental | Experimental Parkinsonisms | Parkinsonisms, Experimental | Parkinson Disease, Experimental | Experimental Parkinsonism, MPTP-Induced | Experimental Parkinsonism, MPTP Induced | Parkinsonism, MPTP-Induced Experimental | MPTP-Induced Experimental Parkinsonism | MPTP Induced Experimental Parkinsonism | Experimental Parkinson Disease | Diseases, Experimental Parkinson | Experimental Parkinson Diseases | Parkinson Diseases, Experimental | Experimental Parkinsonism | Parkinsonism, Juvenile | Juvenile Parkinsonism | Juvenile Parkinsonisms | Parkinsonisms, Juvenile | Parkinson Disease, Juvenile | Juvenile Parkinson Disease | Autosomal Dominant Juvenile Parkinson Disease | Juvenile Parkinson Disease, Autosomal Dominant | Parkinsonism, Juvenile, Autosomal Dominant | Parkinson Disease, Autosomal Dominant. Juvenile | Parkinson Disease, Juvenile, Autosomal Dominant | Autosomal Dominant Juvenile Parkinsonism | Juvenile Parkinsonism, Autosomal Dominant | Autosomal Recessive Parkinsonism | Parkinsonism, Autosomal Recessive | Recessive Parkinsonism, Autosomal
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00879Fentanyl--
BADD_D00913Flucytosine--
BADD_D00931Fluorouracil--
BADD_D00932Fluoxetine0.000108%
BADD_D00935Fluphenazine--
BADD_D00936Fluphenazine decanoate--
BADD_D00937Fluphenazine hydrochloride--
BADD_D00950Fluvoxamine--
BADD_D00979Furosemide0.000035%
BADD_D01023Glimepiride0.000115%
BADD_D01051Halobetasol--
BADD_D01054Haloperidol--
BADD_D01055Haloperidol decanoate--
BADD_D01056Haloperidol lactate--
BADD_D01132Idursulfase--
BADD_D01134Iloperidone--
BADD_D01156Indomethacin--
BADD_D01171Interferon gamma-1b--
BADD_D01243Lamotrigine0.000166%
BADD_D01252Leflunomide0.000428%
BADD_D01257Letrozole0.000790%
BADD_D01303Lithium carbonate0.001606%
BADD_D01304Lithium cation0.001728%
BADD_D01318Lorazepam0.000077%
BADD_D01322Losartan0.000015%
BADD_D01330Lurasidone0.000492%
BADD_D01331Lurasidone hydrochloride--
BADD_D01352Maraviroc--
BADD_D01366Medroxyprogesterone acetate--
BADD_D01378Memantine--
The 2th Page    First    Pre   2 3 4 5    Next   Last    Total 5 Pages
ADReCS-Target
ADR Term Drug Name Target